文献速递甲状腺核医学

胺碘酮诱导的甲状腺毒症中99m锝-甲氧基异丁基异腈甲状腺显像:功能成像与组织病理学的相关性

99m Tc-Sestamibi Thyroid Scintigraphy in Amiodarone-Induced Thyrotoxicosis : Functional Imaging-Histopathologic Correlation.
PubMed 文献 · Clin Nucl Med · 2022-07-15

本文报告4例男性(年龄56-75岁)连续病例,均接受99m锝-甲氧基异丁基异腈甲状腺显像(99mTc-STS)及甲状腺组织学检查,结果均符合2型胺碘酮诱导的甲状腺毒症(AIT)诊断,为该诊断试验首次报道的组织病理学相关性。胺碘酮治疗中位时长26个月(范围10-39个月),4例均在术前中位3个月(范围2-4个月)停用胺碘酮。

要点

  • 4例男性连续病例的99mTc-STS与甲状腺组织学均符合2型AIT诊断。
  • 这是该诊断试验首次报道的组织病理学相关性。
  • 胺碘酮治疗中位26个月,术前中位停药3个月。

核心结论

  • 99mTc-STS是一种有前景的功能成像方法,可能有助于临床医生在AIT的诊断评估和治疗中提供帮助。

研究设计与样本

  • 连续病例系列,共4例男性,年龄56-75岁,均接受99mTc-STS和甲状腺组织学检查。

主要发现

  • 4例的99mTc-STS和甲状腺组织学均符合2型AIT诊断,为该诊断试验首次报道的组织病理学相关性。
  • 胺碘酮治疗中位时长26个月(范围10-39个月)。
  • 4例均在术前中位3个月(范围2-4个月)停用胺碘酮。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

99m Tc-sestamibi thyroid scintigraphy (STS) can aid in differentiating between types 1 and 2 amiodarone-induced thyrotoxicosis (AIT). We present a consecutive case series of 4 men (aged 56-75 years) in whom both 99m Tc-STS and thyroid histology were consistent with a diagnosis of type 2 AIT, representing the first reported histopathologic correlation for this diagnostic test. Median amiodarone treatment duration was 26 months (range, 10-39 months), and amiodarone was discontinued a median of 3 months preoperatively (range, 2-4 months) in all 4 cases. 99m Tc-STS is a promising functional imaging modality, which has the potential to aid clinicians in the diagnostic workup and treatment of AIT.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Wang R, Better N, Sivaratnam D, et al. 99m Tc-Sestamibi Thyroid Scintigraphy in Amiodarone-Induced Thyrotoxicosis : Functional Imaging-Histopathologic Correlation. Clin Nucl Med. 2022. PMID: 35835112. doi:10.1097/RLU.0000000000004332

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。